Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis
Open accessAbstract
CONTEXT: Selective serotonin reuptake inhibitors (SSRIs) are often described as having a delayed onset of effect in the treatment of depression. However, some trials have reported clinical improvement as early as the first week of treatment. OBJECTIVE: To test the alternative hypotheses of delayed vs early onset of antidepressant action with SSRIs in patients with unipolar depression. DATA SOURCES: Trials identified by searching CENTRAL, The Cochrane Collaboration database of controlled trials (2005), and the reference lists of identified trials and other systematic reviews. STUDY SELECTION: Randomized controlled trials of SSRIs vs placebo for the treatment of unipolar depression in adults that reported outcomes for at least 2 time points in the first 4 weeks of treatment (50 trials from >500 citations identified). Trials were excluded if limited to participants older than 65 years or specific comorbidities. DATA EXTRACTION: Data were extracted on trial design, participant characteristics, and outcomes by a single reviewer. DATA SYNTHESIS: Pooled estimates of treatment effect on depressive symptom rating scales were calculated for weeks 1 through 6 of treatment. In the primary analysis, the pattern of response seen was tested against alternative models of onset of response. The primary analysis incorporated data from 28 randomized controlled trials (n=5872). A model of early treatment response best fit the experimental data. Treatment with SSRIs rather than placebo was associated with clinical improvement by the end of the first week of use. A secondary analysis indicated an increased chance of achieving a 50% reduction in Hamilton Depression Rating Scale scores by 1 week (relative risk, 1.64; 95% confidence interval, 1.2-2.25) with SSRI treatment compared with placebo. CONCLUSIONS: Treatment with SSRIs is associated with symptomatic improvement in depression by the end of the first week of use, and the improvement continues at a decreasing rate for at least 6 weeks.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Symptomatic improvement from antidepressant drugs is rarely seen before 1 week.
“symptomatic improvement is rarely seen before 1 week”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Taylor 2007
The molecular, cellular and chemical effects of antidepressant drugs occur very quickly after administration, within hours.
“the molecular, cellular and chemical effects occur very quickly after a drug gets administered, within the course of hours”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Taylor 2007
It generally takes several weeks before symptom relief occurs in patients with depression.
“it generally takes several weeks before symptom relief occurs in patients with depression [28–31].”
From Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial (2023) · cites this paper as [31]
Clinical observations indicate that when SSRIs are used to treat depression, at least 2-4 weeks of treatment is required before effects on symptoms can be expected.
“Delayed effects of the escitalopram intervention align with the clinical observations that when SSRIs are used for treating, e.g., depression, at least 2–4 weeks of treatment is required before effects on symptoms can be expected [29–31].”
From Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial (2023) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · see citing works
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826 · see citing works
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · see citing works
Systematic Reviews: Rationale for systematic reviews
Mulrow, C. D. (1994) · BMJ · doi:10.1136/bmj.309.6954.597 · Cited by 1,677 · see citing works
Current advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113 · see citing works
Development of β-adrenergic receptor subsensitivity by antidepressants
Banerjee, S. P., Kung, L. S., Riggi, S. J., & Chanda, S. K. (1977) · Nature · doi:10.1038/268455a0 · Cited by 722 · see citing works
THE TREATMENT OF DEPRESSIVE STATES WITH G 22355 (IMIPRAMINE HYDROCHLORIDE)
Kuhn, R. (1958) · American Journal of Psychiatry · doi:10.1176/ajp.115.5.459 · Cited by 615 · see citing works
Depression: a case of neuronal life and death?
Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 612 · see citing works
Harmer, C. J., Shelley, N. C., Cowen, P. J., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1256 · Cited by 554 · see citing works
Sanacora, G., Mason, G. F., Rothman, D. L., & Krystal, J. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.663 · Cited by 495 · see citing works
Campbell, M. J., Julious, S. A., & Altman, D. G. (1995) · BMJ · doi:10.1136/bmj.311.7013.1145 · Cited by 476 · see citing works
Modifications of the Serotonin System by Antidepressant Treatments
Blier, P. U., de Montigny, C., & Chaput, Y. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00003 · Cited by 406 · see citing works
How important is publication bias? A synthesis of available data.
Dickersin, K. (1997) · PubMed · Cited by 312 · see citing works
Reimherr, F. W., Chouinard, G., Cohn, C. K., Cole, J. O., Itil, T. M., LaPierre, Y. D., Masco, H. L., & MENDELS, J. (1990) · PubMed · Cited by 263 · see citing works
Lepola, U. M., Loft, H., & Reines, E. H. (2003) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000074988.54339.7c · Cited by 254 · see citing works
Sixteen <i>S</i> ‐squared over <i>D</i> ‐squared: A relation for crude sample size estimates
Lehr, R. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110811 · Cited by 253 · see citing works
Katz, M. M., Tekell, J. L., Bowden, C. L., Brannan, S., Houston, J. P., Berman, N., & Frazer, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300341 · Cited by 252 · see citing works
Is there a delay in the antidepressant effect? A meta-analysis
Posternak, M. A., & Zimmerman, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0201 · Cited by 250 · see citing works
Silverstone, P. H., Ravindran, A. V., & the Venlafaxine XR 360 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0105 · Cited by 246 · see citing works
Bouhuys, A. L., Geerts, E., & Gordijn, M. C. M. (1999) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199910000-00002 · Cited by 235 · see citing works
Wade, A. G., Lemming, O. M., & Hedegaard, K. B. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200205000-00001 · Cited by 232 · see citing works
Bhagwagar, Z., Wylezinska, M., Taylor, M. J., Jezzard, P., Matthews, P. M., & Cowen, P. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.368 · Cited by 227 · see citing works
Self-citationIdentification of True Drug Response to Antidepressants
Quitkin, F. M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190056007 · Cited by 221 · see citing works
Development of The Cochrane Collaboration's Central Register of Controlled Clinical Trials
Dickersin, K., Manheimer, E., Wieland, S., Robinson, K. A., Lefebvre, C., & McDonald, S. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702025001004 · Cited by 198 · see citing works
Use of Pattern Analysis to Identify True Drug Response
Quitkin, F. M. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800150071009 · Cited by 191 · see citing works
Bhagwagar, Z., Cowen, P. J., Goodwin, G. M., & Harmer, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.166 · Cited by 189 · see citing works
Self-citationFabre, L. F., Abuzzahab, F. S., Amin, M., Claghorn, J. L., MENDELS, J., Petrie, W. M., Dubé, S., & Small, J. G. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00178-8 · Cited by 184 · see citing works
Meta-analysis: Unresolved issues and future developments
Smith, G. D., & Egger, M. (1998) · BMJ · doi:10.1136/bmj.316.7126.221 · Cited by 175 · see citing works
Gorman, J. M., Korotzer, A. R., & Su, G. (2002) · CNS Spectrums · doi:10.1017/s1092852900028595 · Cited by 169 · see citing works
The timing, specificity and clinical prediction of tricyclic drug effects in depression
Katz, M. M., Koslow, S. H., Maas, J. W., Frazer, A., Bowden, C. L., Casper, R. C., Croughan, J. L., Kocsis, J. H., & Redmond, E. D. (1987) · Psychological Medicine · doi:10.1017/s0033291700024831 · Cited by 167 · see citing works
Stahl, S. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00957-4 · Cited by 134 · see citing works
Gelenberg, A. J., & Chesen, C. L. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1002 · Cited by 128 · see citing works
(2004) · PubMed · Cited by 117 · see citing works
Antidepressant Treatment of Depression: A Metaanalysis
Joffe, R. T., Sokolov, S. T. H., & Streiner, D. L. (1996) · The Canadian Journal of Psychiatry · doi:10.1177/070674379604101002 · Cited by 116 · see citing works
Lee, S., Walker, J. R., Jakul, L., & Sexton, K. A. (2004) · Depression and Anxiety · doi:10.1002/da.10134 · Cited by 109 · see citing works
Delayed Onset of Action of Antidepressant Drugs? Survey of Results of Zurich Meta-Analyses
Stassen, H. H., Angst, J., & Delini‐Stula, A. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979551 · Cited by 100 · see citing works
A study comparing paroxetine placebo and imipramine in depressed patients.
Feighner, J., Cohn, J., Fabre, L., Fieve, R., Mendels, J., Shrivastava, R., & Dunbar, G. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90035-i · Cited by 82 · see citing works
BYERLEY, W. F., REIMHERR, F. W., WOOD, D. R., & GROSSER, B. I. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198804000-00005 · Cited by 80 · see citing works
A placebo-controlled trial of paroxetine in the treatment of major depression.
Smith, W. T., & Glaudin, V. (1992) · PubMed · Cited by 80 · see citing works
Do Bupropion SR and Sertraline Differ in Their Effects on Anxiety in Depressed Patients?
Trivedi, M. H., Rush, A. J., Carmody, T. J., Donahue, R. M. J., Watson, C. B., Houser, T. L., & Metz, A. L. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1005 · Cited by 75 · see citing works
Bech, P., Tanghøj, P., Cialdella, P., Andersen, H. F., & Pedersen, A. G. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004365 · Cited by 74 · see citing works
A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Dominguez, R. A., Goldstein, B. J., Jacobson, A. F., & Steinbook, R. M. (1985) · PubMed · Cited by 65 · see citing works
Ph.D, M. M. K., Bowden, C. L., Peter Stokes, M. D., Casper, R. C., Frazer, A., Ph.D, S. H. K., James Kocsis, M. D., Steven Secunda, M. D., Alan Swann, M. D., & Ph.D, N. B. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00038-9 · Cited by 64 · see citing works
How long to onset of antidepressant action
Tollefson, G. D., & Holman, S. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400940-00003 · Cited by 63 · see citing works
Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment?
Quitkin, F. M. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00272-f · Cited by 61 · see citing works
Trivedi, M. H., Pigott, T. A., Perera, P., Dillingham, K., Carfagno, M. L., & Pitts, C. D. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1010 · Cited by 58 · see citing works
A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression
Feighner, J. P., Boyer, W. F., Merideth, C., & HENDRICKSON, G. G. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198904000-00004 · Cited by 58 · see citing works
Andreoli, V. M., Caillard, V., Deo, R., RYBAKOWSKI, J. K., & Versiani, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00010 · Cited by 56 · see citing works
Challenges in clinical practice: Pharmacologic and psychosocial strategies
Rifkin, A. E. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:6 · Cited by 56 · see citing works
Fluvoxamine Maleate in the Treatment of Depression
Claghorn, J. L., Earl, C. Q., Walczak, D. D., Stoner, K. A., Wong, L. F., Kanter, D. R., & Houser, V. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604000-00003 · Cited by 54 · see citing works
Walczak, D. D., Apter, J. T., Halikas, J. A., Borison, R. L., Carman, J. S., Post, G., PATRICK, R. O., Cohn, J. N., Cunningham, L. A., Rittberg, B. R., et al. (1996) · Annals of Clinical Psychiatry · doi:10.3109/10401239609147751 · Cited by 47 · see citing works
Paroxetine versus placebo: a double-blind comparison in depressed patients.
Claghorn, J. L., Kiev, A., Rickels, K., Smith, W. T., & Dunbar, G. C. (1992) · PubMed · Cited by 45 · see citing works
Montgomery, S., Bech, P., Blier, P., Möller, H., Nierenberg, A. A., Pinder, R. M., Quitkin, F. M., Reimitz, P., Rosenbaum, J. F., Rush, A. J., et al. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0806 · Cited by 44 · see citing works
A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression
Roth, D. A., Mattes, J. A., Sheehan, K. H., & Sheehan, D. V. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90078-u · Cited by 43 · see citing works
Heiligenstein, J. H., Tollefson, G. D., & Faries, D. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00007 · Cited by 38 · see citing works
A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
Kiev, A. (1992) · PubMed · Cited by 36 · see citing works
Claghorn, J. L. (1992) · PubMed · Cited by 31 · see citing works
Placebo‐Controlled trial of paroxetine in depressive illness
Edwards, J. G., & Goldie, A. (1993) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470080306 · Cited by 14 · see citing works
Placebo‐controlled study of ABT‐200 versus fluoxetine in the treatment of major depressive disorder
Sramek, J. J., Kashkin, K. B., Jasinsky, O., Kardatzke, D. R., Kennedy, S., & Cutler, N. R. (1995) · Depression · doi:10.1002/depr.3050030407 · Cited by 13 · see citing works
Porro, V., Fiorenzioni, S., Menga, C., Cristofaro, A. D., & Bertolino, A. (1988) · Current Therapeutic Research · Cited by 8 · see citing works
ADS's Dexter Data Extraction Applet
Demleitner, M., Accomazzi, A., Eichhorn, G., Grant, C. S., Kurtz, M. J., & Murray, S. (2001) · ASPC · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [24]Alderson P Green S Higgins JPT Cochrane Reviewers' Handbook 4.2.2 2004 Chichester, England John Wiley & Sons Ltd
Cited by
Sorted by citations
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166 · see citing works
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654 · see citing works
Self-citationPRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372 · see citing works
Anderson, I. M., Ferrier, I. N., Baldwin, R., Cowen, P. J., Howard, L. M., Lewis, G., Matthews, K., McAllister-Williams, H., Peveler, R. C., Scott, J. L., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 901 · see citing works
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 850 · see citing works
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759 · see citing works
Self-citationBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632 · see citing works
Kennedy, S. H., Lam, R. W. M., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 526 · see citing works
Effect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients
Harmer, C. J., O’Sullivan, U., Favaron, E., Massey-Chase, R., Ayres, R., Reinecke, A., Goodwin, G. M., & Cowen, P. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020149 · Cited by 485 · see citing works
Neurocognitive Mechanisms in Depression: Implications for Treatment
Clark, L., Chamberlain, S. R., & Sahakian, B. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125618 · Cited by 446 · see citing works
Uher, R., Perlis, R. H., Henigsberg, N., Zobel, A., Rietschel, M., Mors, O., Hauser, J., Dernovsek, M. Z., Souery, D., Bajs, M., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711001905 · Cited by 420 · see citing works
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431 · see citing works
Abnormal temporal difference reward-learning signals in major depression
Kumar, P., Waiter, G., Ahearn, T., Milders, M., Reid, I., & Steele, J. D. (2008) · Brain · doi:10.1093/brain/awn136 · Cited by 374 · see citing works
McCabe, C., Mishor, Z., Cowen, P. J., & Harmer, C. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.001 · Cited by 365 · see citing works
Kelly, J. R., Allen, A. P., Temko, A., Hutch, W., Kennedy, P. J., Farid, N., Murphy, E., Boylan, G., Bienenstock, J., Cryan, J. F., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.11.018 · Cited by 355 · see citing works
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R. C., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 311 · see citing works
Holick, K. A., Lee, D. C., Hen, R., & Dulawa, S. C. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301399 · Cited by 313 · see citing works
Inflammation, Glutamate, and Glia in Depression:<i>A Literature Review</i>
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289 · see citing works
Self-citationEffect of a single dose of citalopram on amygdala response to emotional faces
Murphy, S. E., Norbury, R., O'Sullivan, U., Cowen, P. J., & Harmer, C. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.056093 · Cited by 255 · see citing works
The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments
Machado-Vieira, R., Baumann, J., Wheeler-Castillo, C., Latov, D., Henter, I. D., Salvadore, G., & Zarate, C. A. (2010) · Pharmaceuticals · doi:10.3390/ph3010019 · Cited by 263 · see citing works
Fluvoxamine versus other anti-depressive agents for depression
Omori, I. M., Watanabe, N., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., & Furukawa, T. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006114.pub2 · Cited by 212 · see citing works
Penn, E., & Tracy, D. K. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312445469 · Cited by 207 · see citing works
Jakubovski, E., Varigonda, A. L., Freemantle, N., Taylor, M. J., & Bloch, M. H. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030331 · Cited by 197 · see citing works
Self-citationMachado-Vieira, R., Salvadore, G., Luckenbaugh, D. A., Manji, H. K., & Zarate, C. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0610 · Cited by 195 · see citing works
McCabe, C., & Mishor, Z. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.051 · Cited by 184 · see citing works
Harmer, C. J., & Cowen, P. J. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0407 · Cited by 183 · see citing works
Zheng, W., Zhou, Y.-L., Liu, W.-J., Wang, C.-Y., Zhan, Y.-N., Li, H.-Q., Chen, L.-J., Li, M. D., & Ning, Y.-P. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.09.013 · Cited by 180 · see citing works
A critical review of human endotoxin administration as an experimental paradigm of depression.
DellaGioia, N., & Hannestad, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.014 · Cited by 175 · see citing works
Walker, F. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.002 · Cited by 175 · see citing works
Patel, M. J., Andreescu, C., Price, J. C., Edelman, K. L., Reynolds, C. F., & Aizenstein, H. J. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4262 · Cited by 169 · see citing works
Duloxetine versus other anti-depressive agents for depression
Cipriani, A., Koesters, M., Furukawa, T. A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533.pub2 · Cited by 167 · see citing works
Resting state functional connectivity and treatment response in late-life depression
Andreescu, C., Tudorascu, D. L., Butters, M. A., Tamburo, E., Patel, M., Price, J., Karp, J. F., Reynolds, C. F., & Aizenstein, H. (2013) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2013.08.007 · Cited by 153 · see citing works
Hu, Y.-D., Xiang, Y.-T., Fang, J.-X., Zu, S., Sha, S., Shi, H., Ungvari, G. S., Correll, C. U., Chiu, H. F. K., Xue, Y., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291715002159 · Cited by 146 · see citing works
Smoking Induces Long-Lasting Effects through a Monoamine-Oxidase Epigenetic Regulation
Launay, J., Pino, M. D., Chironi, G. N., Callebert, J., Peoc’h, K., Mégnien, J. L., Mallet, J. J., Simon, A. C., & Rendu, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007959 · Cited by 137 · see citing works
Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders
Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2019) · Depression and Anxiety · doi:10.1002/da.22854 · Cited by 131 · see citing works
Trajectories of change in depression severity during treatment with antidepressants
Uher, R., Muthén, B., Souery, D., Mors, O. N., Jaracz, J., Placentino, A., Petrovic, A., Zobel, A. W., Henigsberg, N., Rietschel, M., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291709991528 · Cited by 128 · see citing works
Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.
Koo, J. W., & Duman, R. S. (2009) · PubMed · Cited by 128 · see citing works
Godlewska, B. R., & Harmer, C. J. (2021) · Psychopharmacology · doi:10.1007/s00213-019-05448-0 · Cited by 123 · see citing works
Pathological Laughing and Crying
Wortzel, H. S., Oster, T. J., Anderson, C. A., & Arciniegas, D. B. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00001 · Cited by 124 · see citing works
Barbui, C., Furukawa, T. A., & Cipriani, A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070693 · Cited by 121 · see citing works
Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region
Taylor, M. J., Sen, S., & Bhagwagar, Z. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.034 · Cited by 118 · see citing works
Self-citationTadić, A., Helmreich, I., Mergl, R., Hautzinger, M., Kohnen, R., Henkel, V., & Hegerl, U. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.014 · Cited by 113 · see citing works
Trajectories of Depression Severity in Clinical Trials of Duloxetine
Gueorguieva, R. V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.132 · Cited by 114 · see citing works
Short-term antidepressant treatment modulates amygdala response to happy faces
Norbury, R., Taylor, M. J., Selvaraj, S., Murphy, S. E., Harmer, C. J., & Cowen, P. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1597-1 · Cited by 109 · see citing works
Self-citationThe effects of serotonin manipulations on emotional information processing and mood
Merens, W., van der Does, W. A. J., & Spinhoven, P. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.032 · Cited by 108 · see citing works
Dentate gyrus neurogenesis and depression
Sahay, A., Drew, M. R., & Hen, R. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63038-6 · Cited by 102 · see citing works
Hieronymus, F., Nilsson, S., & Eriksson, E. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.104 · Cited by 100 · see citing works
Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B. M., Brand, U., Fleischhacker, W., Goodwin, G. M., Grunze, H., Knapp, M. R. J., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 98 · see citing works
Medical cannabis treatment for chronic pain: Outcomes and prediction of response
Aviram, J., Pud, D., Gershoni, T., Schiff‐Keren, B., Ogintz, M., Vulfsons, S., Yashar, T., Adahan, H., Brill, S., Amital, H., et al. (2020) · European Journal of Pain · doi:10.1002/ejp.1675 · Cited by 98 · see citing works
Taliaz, D., Spinrad, A., Barzilay, R., Barnett-Itzhaki, Z., Averbuch, D., Teltsh, O., Schurr, R., Darki-Morag, S., & Lerer, B. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01488-3 · Cited by 93 · see citing works
Varigonda, A. L., Jakubovski, E., & Bloch, M. H. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.07.768 · Cited by 92 · see citing works
A new paradigm for the prediction of antidepressant treatment response
Leuchter, A. F., Cook, I. A., Hunter, A. M., & Korb, A. S. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.4/afleuchter · Cited by 90 · see citing works
Prognostic Subgroups for Citalopram Response in the STAR*D Trial
Jakubovski, E., & Bloch, M. H. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08727 · Cited by 85 · see citing works
Onset, time course and trajectories of improvement with antidepressants
Lam, R. W. M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.005 · Cited by 84 · see citing works
Plasma serotonin levels are associated with antidepressant response to SSRIs
Holck, A., Wolkowitz, O. M., Mellon, S. H., Reus, V. I., Nelson, J. C., Westrin, Å., & Lindqvist, D. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.063 · Cited by 84 · see citing works
An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress
Lu, J., Tjia, M., Mullen, B., Cao, B., Lukasiewicz, K., Shah-Morales, S., Weiser, S., Cameron, L. P., Olson, D. E., Chen, L., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01159-1 · Cited by 84 · see citing works
A mechanistic account of serotonin’s impact on mood
Michely, J., Eldar, E., Martin, I. M., & Dolan, R. J. (2020) · Nature Communications · doi:10.1038/s41467-020-16090-2 · Cited by 72 · see citing works
Tran, P., Skolnick, P., Czobor, P., Huang, N. Y., Bradshaw, M., McKinney, A., & Fava, M. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.003 · Cited by 81 · see citing works
Simmons, A. N., Arce, E., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990149 · Cited by 80 · see citing works
Anderson, M. H., Munafo, M. R., & Robinson, E. S. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2932-5 · Cited by 79 · see citing works
The History and Current State of Antidepressant Clinical Trial Design
Gelenberg, A. J., Thase, M. E., Meyer, R. E., Goodwin, F. K., Katz, M. M., KRAEMER, H. C., Potter, W. Z., Shelton, R. C., D, M. F. M., Khan, A., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1001 · Cited by 77 · see citing works
Monoamine oxidases in development
Wang, C. C., Billett, E. E., Borchert, A., Kühn, H., & Ufer, C. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1065-7 · Cited by 77 · see citing works
Wagner, S., Engel, A., Engelmann, J., Herzog, D., Dreimüller, N., Müller, M. B., Tadić, A., & Lieb, K. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.003 · Cited by 73 · see citing works
Connecting Dots between Mitochondrial Dysfunction and Depression
Khan, M., Baussan, Y., & Hébert-Chatelain, É. (2023) · Biomolecules · doi:10.3390/biom13040695 · Cited by 77 · see citing works
Cipriani, A., Geddes, J. R., Furukawa, T. A., & Barbui, C. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200903 · Cited by 72 · see citing works
Self-citationAccelerating response to antidepressant treatment in depression: a review and clinical suggestions.
Nakajima, S., Suzuki, T., Watanabe, K., Kashima, H., & Uchida, H. (2010) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.12.001 · Cited by 78 · see citing works
Bui, E., Nadal-Vicens, M., & M. Simon, N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.2/ebui · Cited by 71 · see citing works
Barbon, A., Caracciolo, L., Orlandi, C., Musazzi, L., Mallei, A., Via, L. L., Bonini, D., Mora, C., Tardito, D., Gennarelli, M., et al. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.07.013 · Cited by 70 · see citing works
James, G. M., Baldinger, P., Philippe, C., Kranz, G. S., Vanicek, T., Hahn, A., Gryglewski, G., Hienert, M., Spies, M., Traub‐Weidinger, T., et al. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00048 · Cited by 69 · see citing works
Brunoni, A. R., Valiengo, L. D. C. L., Baccaro, A., Zanao, T. A., de Oliveira, J. F., Vieira, G. P., Bueno, V. F., Goulart, A. C., Boggio, P. S., Lotufo, P. A., et al. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.09.007 · Cited by 69 · see citing works
Initiation of Behavioral Response to Antidepressants by Cholecystokinin Neurons of the Dentate Gyrus
Medrihan, L., Sagi, Y., Inde, Z., Krupa, O., Daniels, C., Peyrache, A., & Greengard, P. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.044 · Cited by 68 · see citing works
Aust, S., Gärtner, M., Basso, L., Otte, C., Wingenfeld, K., Chae, W. R., Heuser, I., Regen, F., Cosma, N. C., van Hall, F., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.02.005 · Cited by 68 · see citing works
Future Suicide Attempt and Responses to Serotonergic Challenge
Keilp, J. G., Oquendo, M. A., Stanley, B., Burke, A. K., Cooper, T. B., Malone, K. M., & Mann, J. J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.28 · Cited by 67 · see citing works
A neurocognitive model for understanding treatment action in depression
Warren, M., Pringle, A., & Harmer, C. J. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0213 · Cited by 66 · see citing works
A unified model of ketamine’s dissociative and psychedelic properties
Marguilho, M., Figueiredo, I., & Castro-Rodrigues, P. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221140011 · Cited by 65 · see citing works
The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study
Norbury, R., Mackay, C. E., Cowen, P. J., Goodwin, G. M., & Harmer, C. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002091 · Cited by 65 · see citing works
Dreimüller, N., Schlicht, K. F., Wagner, S., Peetz, D., Borysenko, L., Hiemke, C., Lieb, K., & Tadić, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.017 · Cited by 63 · see citing works
Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
Khan, A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903286396 · Cited by 64 · see citing works
Depression in primary care: part 2—management
Ramanuj, P., Ferenchick, E. K., & Pincus, H. A. (2019) · BMJ · doi:10.1136/bmj.l835 · Cited by 62 · see citing works
Efficacy and Safety of Vilazodone in Major Depressive Disorder
Croft, H. A., Pomara, N., Gommoll, C., Chen, D., Núñez, R., & Mathews, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m08992 · Cited by 63 · see citing works
Baldwin, D. S., Stein, D. J., Dolberg, O. T., & Bandelow, B. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1019 · Cited by 63 · see citing works
Kemp, D. E., Ganocy, S. J., Brecher, M., Carlson, B. X., Edwards, S., Eudicone, J. M., Evoniuk, G. E., Jansen, W. T., Leon, A. C., Minkwitz, M. C., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.026 · Cited by 61 · see citing works
Antidepressants and the adolescent brain
Cousins, L., & Goodyer, I. M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573542 · Cited by 61 · see citing works
Huizink, A. C., & de Rooij, S. R. (2018) · Development and Psychopathology · doi:10.1017/s0954579418000354 · Cited by 62 · see citing works
Bedson, E., Bell, D., Carr, D. F., Carter, B., Hughes, D. A., Jorgensen, A., Lewis, H., Lloyd, K. R., McCaddon, A., Moat, S. J., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18480 · Cited by 60 · see citing works
LADER, M. H. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.05.004 · Cited by 59 · see citing works
Erritzøe, D., Barba, T., Greenway, K. T., Murphy, R., Martell, J., Giribaldi, B., Timmermann, C., Murphy-Beiner, A., Baker-Jones, M., Nutt, D., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102799 · Cited by 63 · see citing works
Ookubo, M., Kanai, H., Aoki, H., & Yamada, N. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.028 · Cited by 57 · see citing works
Hegerl, U., & Mergl, R. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109106930 · Cited by 54 · see citing works
Scholl, J., Kolling, N., Nelissen, N., Browning, M., Rushworth, M. F. S., & Harmer, C. J. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2000756 · Cited by 58 · see citing works
Varigonda, A. L., Jakubovski, E., Taylor, M. J., Freemantle, N., Coughlin, C. G., & Bloch, M. H. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.05.004 · Cited by 55 · see citing works
Self-citationGrilo, C. M., & Masheb, R. M. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2007.05.010 · Cited by 55 · see citing works
Tan, S. K. H., Hartung, H., Visser-Vandewalle, V. E. R. M., Steinbusch, H. W. M., Temel, Y., & Sharp, T. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.027 · Cited by 53 · see citing works
Antidepressant-related sexual dysfunction — Perspectives from neuroimaging
Graf, H., Walter, M., Metzger, C. D., & Abler, B. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.12.003 · Cited by 53 · see citing works
Warden, S. J., & Haney, E. M. (2008) · PubMed · Cited by 53 · see citing works
Current and emerging drug treatments for binge eating disorder
Reas, D. L., & Grilo, C. M. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.879291 · Cited by 52 · see citing works
Cheng, Y., Xu, J., Arnone, D., Nie, B., Yu, H., Jiang, H., Bai, Y., Luo, C., Campbell, R. A. A., Shan, B., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291716002440 · Cited by 51 · see citing works
Antidepressant drug action--From rapid changes on network function to network rewiring
Rantamäki, T., & Yalcin, I. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.001 · Cited by 50 · see citing works
Johansen, A., Armand, S., Plavén-Sigray, P., Nasser, A., Ozenne, B., Petersen, I. N., Keller, S. H., Madsen, J., Beliveau, V., Møller, K., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02285-8 · Cited by 53 · see citing works
de Vries, Y. A., Roest, A. M., Bos, E. H., Burgerhof, J. G. M., van Loo, H. M., & de Jonge, P. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.122 · Cited by 50 · see citing works
- Authors
- Taylor, M. J., Freemantle, N., Geddes, J. R., & Bhagwagar, Z.
- Affiliations
- Warneford Hospital (GB)
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2006-11-01
- Volume
- 63
- Issue
- 11
- Pages
- 1217
- ISSN
- 0003-990X (ISSN-L)
- PMC
- PMC2211759
- OpenAlex
- W2140505555
- Cited by
- 406
- References
- 62
- Citations by year
- 2026: 20 · 2025: 31 · 2024: 17 · 2023: 25 · 2022: 18 · 2021: 14 · 2020: 14 · 2019: 16 · 2018: 12 · 2017: 12 · 2016: 15 · 2015: 21 · 2014: 15 · 2013: 23 · 2012: 29
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Wellcome Trust (075694)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- selective serotonin reuptake inhibitors, antidepressant onset of action, major depressive disorder, early treatment response, placebo comparison, Hamilton Depression Rating Scale, antidepressant efficacy
- MeSH terms
- Adult, Age Factors, Depressive Disorder, Double-Blind Method, Humans, Middle Aged, Placebos, Psychiatric Status Rating Scales, Research Design, Risk, Time Factors, Confidence Intervals, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review